A Safety and Efficacy Comparison of BLI4700 Bowel Prep Versus an FDA-approved Comparator in Adults Prior to Colonoscopy
Public ClinicalTrials.gov record NCT03404401. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
BLI4700-301: A Safety and Efficacy Comparison of BLI4700 Bowel Preparation Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy
Study identification
- NCT ID
- NCT03404401
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Braintree Laboratories
- Industry
- Enrollment
- 620 participants
Conditions and interventions
Conditions
Interventions
- BLI4700 Drug
- Polyethylene glycol bowel preparation Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 10, 2018
- Primary completion
- Jul 9, 2018
- Completion
- Jul 9, 2018
- Last update posted
- Sep 7, 2021
2018
United States locations
- U.S. sites
- 23
- U.S. states
- 15
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Braintree Research Site 212 | Mobile | Alabama | 36688 | — |
| Braintree Research Site 204 | Tucson | Arizona | 85712 | — |
| Braintree Research Site 209 | Anaheim | California | 92801 | — |
| Braintree Research Site 219 | Chula Vista | California | 91910 | — |
| Braintree Research Site 206 | Los Angeles | California | 90045 | — |
| Braintree Research Site 220 | San Diego | California | 92114 | — |
| Braintree Research Site 221 | Inverness | Florida | 34452 | — |
| Braintree Research Site 222 | Jacksonville | Florida | 32216 | — |
| Braintree Research Site 201 | Palm Harbor | Florida | 34684 | — |
| Braintree Research Site 224 | Atlanta | Georgia | 30342 | — |
| Braintree Research Site 215 | Decatur | Georgia | 30033 | — |
| Braintree Research Site 223 | Lake Charles | Louisiana | 70601 | — |
| Braintree Research Site 211 | Monroe | Louisiana | 71201 | — |
| Braintree Research Site 207 | Hagerstown | Maryland | 21742 | — |
| Braintree Research Site 218 | Flowood | Mississippi | 39232 | — |
| Braintree Research Site 210 | Great Neck | New York | 11023 | — |
| Braintree Research Site 214 | Cincinnati | Ohio | 45219 | — |
| Braintree Research Site 213 | Portland | Oregon | 97210 | — |
| Braintree Research Site 216 | Columbia | South Carolina | 29203 | — |
| Braintree Research Site 202 | Franklin | Tennessee | 37067 | — |
| Braintree Research Site 203 | Jackson | Tennessee | 38305 | — |
| Braintree Research Site 217 | Ogden | Utah | 84405 | — |
| Braintree Research Site 208 | Milwaukee | Wisconsin | 53215 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03404401, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 7, 2021 · Synced Jun 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03404401 live on ClinicalTrials.gov.